Despite global commitments to eliminate viral hepatitis by 2030, progress remains uneven. The Polaris Observatory tracks data from over 170 countries to evaluate hepatitis B (HBV) and C (HCV) elimination. While some nations have made significant strides—particularly in HCV treatment and HBV vaccination—few are on track to meet WHO’s full elimination targets. Barriers include complex HBV treatment guidelines, limited testing access, and underinvestment. Conversely, success in HCV elimination has been driven by political commitment, affordable diagnostics and drugs, and decentralized service delivery. Strategic simplification of HBV guidelines and expanded investment are essential to prevent HBV and HCV from becoming the leading causes of infectious disease mortality.

Read the Full Report